Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

IMRA America Inc.

Facebook Twitter LinkedIn Email Comments
IMRA America Inc. of Ann Arbor, Mich., and MagArray Inc. of Sunnyvale, Calif., will collaborate to develop MagArray’s magneto-nanoparticle immunoassay technology, which is based on research from Stanford University in California. The companies will develop highly sensitive immunoassay sensor systems. If the work progresses as planned, IMRA will support MagArray’s development with funding of up to $10 million over the next three and a half years. IMRA also will provide scientific and technical support, including nanomaterial technologies. MagArray’s technology could play a leading role in the way that cancer and other serious diseases are diagnosed and treated, said Takashi Omitsu, IMRA’s president.


BioPhotonics
Jan 2012
AmericasBiophotonicsBusinessfiber laser researchfiber opticsimagingimmunoassay sensor systemsImra Americalaser-made nanoparticlesMagArrayMagArray magneto-nanoparticle immunoassay technologynanonanomaterials technologyRapidScanSensors & DetectorsStanford UniversityTakashi Omitsulasers

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.